NuVasive Investor Relations

NuVasive is a world leader in minimally invasive, procedurally integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes.

Analyst Coverage

Firm Analyst
Bank of America / Merrill Lynch
 Craig Bijou
Barclays
 Matt Miksic
BTIG
 Ryan Zimmerman
Canaccord Genuity
 Kyle Rose
Citi
 Joanne Wuensch
Cowen and Company
 Josh Jennings, MD
Jefferies
 Matthew Taylor
JMP Securities
 David Turkaly
JP Morgan
 Allen Gong
Loop Capital Markets
 Jason Wittes
Morgan Stanley
 Drew Ranieri
Needham and Company
 Mike Matson
Piper Sandler
 Matthew O’Brien
RBC Capital Markets
 Shagun Singh
Robert W. Baird & Co.
Jeff D. Johnson
Stifel Nicolaus
 Mathew Blackman
Truist
Richard Newitter
Wells Fargo
 Vik Chopra

Nuvasive Inc is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Nuvasive Inc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Nuvasive Inc or its management. Nuvasive Inc does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

The materials on this website are for your general educational information only. Information you read on this website cannot replace the relationship that you have with your healthcare professional. We do not practice medicine or provide medical services or advice as a part of this website. You should always talk to your healthcare professional for diagnosis and treatment.